Jay Haynie
Optometrist · Tacoma, WANPI 1841360302
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $25,807 of the $41,196 with a category attached, or 62.6%. 10 manufacturers reported payments, led by Topcon Healthcare, Inc. at 53.4% of the total. Reporting peaked in 2020 at $12,000 and has fallen 89.5% since, to $1,259 in 2025. Among optometrist clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $823.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Topcon Healthcare, Inc.$22K
- Apellis Pharmaceuticals, Inc.$8K
- Carl Zeiss Meditec, Inc.$8K
- Regeneron$2K
- Astellas Pharma US Inc$234
- Carl Zeiss Meditec USA, Inc.$219
- plus $397 from 4 others
Across 13 payments — averaging $46.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$600
What the payments were for
- Consulting fees$25,80763%
- Speaking & faculty fees$10,47125%
- Travel & lodging$2,8957%
- Food & beverage$2,0235%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Topcon Healthcare, Inc. | 4 | $22,000 |
| Apellis Pharmaceuticals, Inc. | 16 | $8,471 |
| Carl Zeiss Meditec, Inc. | 17 | $7,630 |
| Regeneron | 2 | $2,245 |
| Astellas Pharma US Inc | 3 | $234 |
| Carl Zeiss Meditec USA, Inc. | 2 | $219 |
| Eyepoint US, Inc. | 2 | $131 |
| Regeneron Healthcare Solutions, Inc. | 2 | $125 |
| Genentech USA, Inc. | 1 | $123 |
| Bausch & Lomb Americas Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OCT MAESTRO$12,000
- DRI-OCT-TRITON$10,000
- CIRRUS HD-OCT$7,125
- FORUM$7,125
- CLARUS 500 Fundus Camera$7,125
- Syfovre$6,247
- Humphrey HFA$3,296
- EYLEA$2,245
- Glaucoma Workplace$1,000
- CLARUS 500$165
- SUSVIMO$123
- YUTIQ$111
How this compares
$41,196 in reported general payments places this provider in the 95th percentile of 1,267 optometrist providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 285 | $9,355 |
| Ketorolac Tromethamine | 84 | $2,018 |
| Difluprednate | 20 | $1,549 |
| Acetazolamide | 29 | $805 |
| Dorzolamide Hcl | 42 | $639 |
| Brimonidine Tartrate | 54 | $510 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 27 | $420 |
| Timolol Maleate | 43 | $352 |
| Ciprofloxacin Hcl | 38 | $305 |
| Latanoprost | 35 | $258 |
| Diclofenac Sodium | 19 | $213 |
| ErythromycinErythromycin Base | 12 | $130 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Tacoma
- Alan ChousTacoma$115K
- Thanh PhamTacoma$10K
- Michael NobleTacoma$6K
- Joel JansenTacoma$6K
- Barry HuseTacoma$6K
- David KadingKirkland$397K
- Peter BergenskeOtis Orchards$355K
- Casey ClaypoolSpokane Valley$323K
- Charles ClaytonBellevue$195K
- Herminder BoparaiBellevue$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.